Therefore, they proposed to treat pregnant psoriasis patients with anti-IL-17 (secukinumab) and evaluate the incidence of ASD in the offspring, if the incidence rate is reduced this could prove a relationship between MIA (maternal immune activation) and ASD through IL-17 signaling (12). This evidence concerns the gene IL17A and psoriasis.